Target intelligence / Profile preview

Gastric acid (free form)

Molecular classification
Other
01

Overview

Gastric acid, primarily hydrochloric acid (HCl), is secreted by parietal cells of the stomach and is the main acidic component in gastric juice. Its low pH (1–3) is crucial for activating digestive enzymes (notably, the conversion of pepsinogen to pepsin), aiding in the digestion of proteins and absorption of certain nutrients and minerals, and acting as an antimicrobial barrier to prevent pathogens from reaching the intestines. Acid secretion is regulated by neural (vagus nerve), hormonal (gastrin, somatostatin), and paracrine (histamine) mechanisms. While essential for normal gastrointestinal function, imbalances in free gastric acid—either excess (hyperchlorhydria) or deficiency (hypochlorhydria)—are implicated in a range of diseases such as peptic ulcers, gastritis, and increased susceptibility to gastrointestinal infections. Pharmacological agents frequently target the acid secretion process itself, not the acid as a molecule[1][2][3][4][5][6][7]. Note: "Free gastric acid" is not a therapeutic target or druggable protein/receptor, making it an incorrect entry as a target. It refers to a measurable chemical/physiological property, not a molecule amenable to direct modulation by drugs as a receptor or enzyme is.

Other names
Stomach acidfree HClunbound gastric hydrochloric acidgastric juice acid component
02

Mechanism of action

Drugs reduce gastric acid secretion by inhibiting H+/K+ ATPase (proton pump inhibitors), blocking H2 receptors on parietal cells (H2RAs), or neutralizing the acid (antacids)[3].

03

Biological functions

Protein digestion (via activation of pepsinogen to pepsin)Nutrient absorption (B12, iron, calcium)Innate antimicrobial defense
04

Disease associations

GastritisPeptic ulcer diseaseInfection susceptibility (when suppressed)
05

Safety considerations

Long-term acid suppression increases infection risk (e.g., C. difficile), nutritional deficiencies (B12, iron)[6][7].Acid hypersecretion can cause mucosal damage (ulcers)
06

Interacting drugs

Proton pump inhibitors (omeprazole, lansoprazole, etc.)

2 more in the full profile.

Beyond the preview

Go deeper on Gastric acid (free form).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric acid (free form).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call